Neurotech, Neuromodulation, Alzheimers.
had positive results and one did not. News coverage seems to cite financial pressures to come up with positive news, which indeed spiked their stock price. And so, this is not to say efforts don’t continue. A 2020 survey article is a good assessment of the future of treatment in the wake of